No abstract available
Keywords:
immunotherapeutics; nanocarriers; site-directed diagnosis or imaging; stimuli-responsive; theragnosis; tumor targeting.
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.